Tradewinds Global Investors’s Impax Laboratories, Inc. IPXL Stock Holding History

Tradewinds Global Investors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.18M	Sell	49,661 -270,891	-85%	-$7.28M	1.45%	32
2016 Q2	$9.24M	Buy	320,552 +114,239	+55%	+$3.72M	0.6%	57
2016 Q1	$6.61M	Buy	206,313 +21,996	+12%	+$773K	0.4%	71
2015 Q4	$7.88M	Buy	184,317 +20,099	+12%	+$803K	0.46%	70
2015 Q3	$5.78M	Sell	164,218 -20,814	-11%	-$938K	0.29%	76
2015 Q2	$8.5M	Sell	185,032 -25,655	-12%	-$1.22M	0.37%	74
2015 Q1	$9.87M	Sell	210,687 -162,009	-43%	-$6.45M	0.4%	62
2014 Q4	$11.8M	Sell	372,696 -546,037	-59%	-$16M	0.48%	63
2014 Q3	$21.8M	Buy	918,733 +675,919	+278%	+$17.3M	0.8%	49
2014 Q2	$7.28M	Sell	242,814 -20,027	-8%	-$540K	0.25%	72
2014 Q1	$6.94M	Sell	262,841 -27,057	-9%	-$676K	0.17%	78
2013 Q4	$7.29M	Sell	289,898 -384,425	-57%	-$8.58M	0.18%	78
2013 Q3	$13.8M	Buy	+674,323	New	+$13.9M	0.37%	67

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tradewinds Global Investors's IPXL Position: Q3 2016 in Review

Tradewinds Global Investors reduced its Impax Laboratories, Inc. (IPXL) stake by 85% in Q3 2016, selling an estimated $7.28M and leaving 49,661 shares worth $1.18M. The position accounts for 1.45% of the portfolio, ranked #32.

Tradewinds Global Investors first reported a position in IPXL in Q3 2013 and has held it in 13 quarters since. The position peaked at $21.8M in Q3 2014. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

Tradewinds Global Investors held 49,661 shares of Impax Laboratories, Inc. worth $1.18M as of Q3 2016.
Tradewinds Global Investors sold 270,891 Impax Laboratories, Inc. shares in Q3 2016, an estimated $7.28M.
Impax Laboratories, Inc. made up 1.45% of Tradewinds Global Investors's portfolio in Q3 2016, its #32 holding.
Tradewinds Global Investors first reported a position in Impax Laboratories, Inc. in Q3 2013 and has held it in 13 quarters since.
Tradewinds Global Investors's Impax Laboratories, Inc. position peaked at $21.8M in Q3 2014.
196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Tradewinds Global Investors's 13F filing for Q3 2016, filed 14 Nov 2016.